[Federal Register Volume 90, Number 242 (Friday, December 19, 2025)]
[Rules and Regulations]
[Pages 59393-59397]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-23424]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2024-0631; FRL 13060-01-OCSPP]


Thiamethoxam; Pesticide Tolerances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes tolerances for residues of 
thiamethoxam in or on pepper, black at 0.15 parts per million (ppm). 
Under the Federal Food, Drug, and Cosmetic Act (FFDCA), the American 
Spice Trade Association submitted a petition to EPA requesting that EPA 
establish a maximum permissible level for residues of this pesticide in 
or on this commodity.

DATES: This rule is effective on December 19, 2025. Objections and 
requests for hearings must be received on or before February 17, 2026 
and must be filed in accordance with the instructions provided in 40 
CFR part 178 (see also Unit I.C. of this document).

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPP-2024-0631, is available at 
https://www.regulations.gov. Additional instructions on commenting or 
visiting the docket, along with more information about dockets 
generally, is available at https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Charles Smith, Registration Division 
(7505T), Office of Pesticide Programs, Environmental Protection Agency, 
1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: 
(202) 566-2427; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. Executive Summary

A. Does this action apply to me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
The following list of North American Industrial Classification System 
(NAICS) codes is not intended to be exhaustive, but rather provides a 
guide to help readers determine whether this document might apply to 
them:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).
    If you have any questions regarding the applicability of this 
action to a particular entity, consult the person listed under FOR 
FURTHER INFORMATION CONTACT.

B. What is EPA's authority for taking this action?

    EPA is issuing this rulemaking under section 408 of the Federal 
Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a. FFDCA section 
408(b)(2)(A)(i) allows EPA to establish a tolerance (the legal limit 
for a pesticide chemical residue in or on a food) only if EPA 
determines that the tolerance is ``safe.'' FFDCA section 
408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable 
certainty that no harm will result from aggregate exposure to the 
pesticide chemical residue, including all anticipated dietary exposures 
and all other exposures for which there is reliable information.'' This 
includes exposure through drinking water and in residential settings 
but does not include occupational exposure. FFDCA section 408(b)(2)(C) 
requires EPA to give special consideration to exposure of infants and 
children to the pesticide chemical residue in establishing a tolerance 
and to ``ensure that there is a reasonable

[[Page 59394]]

certainty that no harm will result to infants and children from 
aggregate exposure to the pesticide chemical residue . . .''

C. How can I file an objection or hearing request?

    Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file 
an objection to any aspect of this regulation and may also request a 
hearing on those objections. If you fail to file an objection to the 
final rule within the time period specified in the final rule, you will 
have waived the right to raise any issues resolved in the final rule. 
You must file your objection or request a hearing on this regulation in 
accordance with the instructions provided in 40 CFR part 178. To ensure 
proper receipt by EPA, you must identify docket ID number EPA-HQ-OPP-
2024-0217 in the subject line on the first page of your submission. All 
objections and requests for a hearing must be in writing and must be 
received by the Hearing Clerk on or before February 17, 2026.
    The EPA's Office of Administrative Law Judges (OALJ), in which the 
Hearing Clerk is housed, urges parties to file and serve documents by 
electronic means only, notwithstanding any other particular 
requirements set forth in other procedural rules governing those 
proceedings. See ``Revised Order Urging Electronic Filing and 
Service,'' dated June 22, 2023, which can be found at https://www.epa.gov/system/files/documents/2023-06/2023-06-22%20-%20revised%20order%20urging%20electronic%20filing%20and%20service.pdf. 
Although the EPA's regulations require submission via U.S. Mail or hand 
delivery, the EPA intends to treat submissions filed via electronic 
means as properly filed submissions; therefore, the EPA believes the 
preference for submission via electronic means will not be prejudicial. 
When submitting documents to the OALJ electronically, a person should 
utilize the OALJ e-filing system at https://yosemite.epa.gov/oa/eab/eab-alj_upload.nsf.
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing (excluding any Confidential Business Information (CBI)) for 
inclusion in the public docket at https://www.regulations.gov. Follow 
the online instructions for submitting comments. Do not submit 
electronically any information you consider to be CBI or other 
information whose disclosure is restricted by statute. If you wish to 
include CBI in your request, please follow the applicable instructions 
at https://www.epa.gov/dockets/commenting-epa-dockets#rules and clearly 
mark the information that you claim to be CBI. Information not marked 
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA 
without prior notice.

II. Petitioned-For Tolerance

    In the Federal Register of July 3, 2025 (90 FR 29515 (FRL-12474-05-
OCSPP)), EPA issued a document pursuant to FFDCA section 408(d)(3), 21 
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 
4F9156) by the American Spice Trade Association. The petition requested 
that 40 CFR part 180 be amended by establishing tolerances for residues 
of the insecticide thiamethoxam in or on pepper, black at 0.1 ppm. That 
document referenced a summary of the petition that was prepared by the 
petitioner and is included in the docket. No comments were received in 
response to that notice of filing.

III. Final Tolerance Action

A. Aggregate Risk Assessment and Determination of Safety

    Consistent with FFDCA section 408(b)(2)(D), and the factors 
specified therein, EPA has reviewed the available scientific data and 
other relevant information in support of this action. Based upon review 
of the data supporting the petition and in accordance with its 
authority under FFDCA section 408(d)(4)(A)(i), EPA is establishing a 
tolerance that varies from what the petitioner sought. Specifically, 
EPA is establishing a tolerance of 0.15 ppm (versus the petitioned-for 
0.1 ppm) because the monitoring data the tolerance is based upon 
demonstrate that a tolerance of 0.15 ppm is the appropriate level.
    EPA has determined that it has sufficient data to assess the 
hazards of and to make a determination on aggregate exposure for 
thiamethoxam, including exposure resulting from the tolerance 
established by this action. EPA's assessment of exposures and risks 
associated with thiamethoxam is summarized in this unit.
    In an effort to streamline its publications in the Federal 
Register, EPA is not reprinting discussions previously published in 
other tolerance rulemakings for the same pesticide chemical. Where 
scientific information concerning a particular chemical remains 
unchanged, the content of those sections would not vary between 
tolerance rulemakings, and EPA considers referral back to those 
sections as sufficient to provide an explanation of the information EPA 
considered in making its safety determination for this new rulemaking.
    For thiamethoxam, EPA has previously published tolerance 
rulemakings in which EPA concluded, based on the available information, 
that there is a reasonable certainty that no harm would result from 
aggregate exposure to thiamethoxam and established tolerances for 
residues of that chemical. EPA is incorporating previously published 
sections from previous rulemakings as described further in this 
rulemaking, as they remain unchanged.
    Tolerances for residues of thiamethoxam are listed in 40 CFR 
180.565 and are expressed in terms of the combined residues of the 
insecticide thiamethoxam and its metabolites and degradates, including 
its metabolite CGA-322704. CGA-322704 is also the registered active 
ingredient clothianidin, for which tolerances are listed in 40 CFR 
180.586. Clothianidin (hereinafter referred to as CGA-322704) has a 
complete toxicological database and appears to have effects in mammals 
that are different from those of thiamethoxam. A separate risk 
assessment that addresses risks from CGA-322704 residues resulting from 
the direct application of CGA-322704 (clothianidin), as well as risks 
from residues of CGA-322704 coming from thiamethoxam uses has been 
conducted, and there are no risk estimates of concern as a result of 
the proposed tolerance for thiamethoxam residues in or on black pepper.
    Specific information on the risk assessments conducted in support 
of this action, including on the studies received and the nature of the 
adverse effects caused by thiamethoxam and CGA-322704, can be found in 
the documents titled ``Thiamethoxam. Human Health Risk Assessment for 
Use on Imported Black Pepper'' (hereinafter ``Thiamethoxam Human Health 
Risk Assessment'') and ``Clothianidin. Human Health Risk Assessment to 
Address Exposure Associated with a New Tolerance for Thiamethoxam in/on 
Imported Black Pepper'' (hereinafter ``Clothianidin Human Health Risk 
Assessment''), which are available in the docket for this action.

B. Toxicological Profile

    For a discussion of the toxicological profile of thiamethoxam, see 
Unit III.A. of the thiamethoxam tolerance rulemaking published in the 
Federal Register of February 15, 2017 (82 FR 10712) (FRL-9957-00).

[[Page 59395]]

C. Toxicological Points of Departure/Levels of Concern

    For a summary of the toxicological points of departure (PODs)/
levels of concern for thiamethoxam used for human health risk 
assessment, see Unit III.B. of the February 15, 2017, rulemaking (82 FR 
10712) (FRL-9957-00).

D. Exposure Assessment

    Much of the exposure assessment remains the same although updates 
have occurred to account for exposures from the petitioned-for 
tolerance. These updates are discussed in this section; for a 
description of the rest of the EPA approach to and assumptions for the 
exposure assessment, see Unit III.C. of the February 15, 2017, 
rulemaking (82 FR 10712) (FRL-9957-00).
    1. Dietary exposure from food and feed uses. In evaluating dietary 
exposure to thiamethoxam, EPA considered exposure under the petitioned-
for tolerance as well as all existing thiamethoxam tolerances in 40 CFR 
180.565. The assessments were conducted using the Dietary Exposure 
Evaluation Model software with the Food Commodity Intake Database 
(DEEM-FCID) Version 4.02. EPA used 2005-2010 food consumption 
information from the United States Department of Agriculture's National 
Health and Nutrition Examination Survey, What We Eat in America. EPA 
assessed dietary exposures from thiamethoxam in food as follows:
    i. Acute exposure. The acute assessment is based on tolerance-level 
residues and assumes 100 percent crop treated (PCT); the acute 
assessment is unrefined.
    ii. Chronic exposure. The chronic assessment is based on average 
residues from crop field trials and assumes 100 PCT; the chronic 
assessment is moderately refined.
    iii. Cancer. EPA has concluded that thiamethoxam is not likely to 
be carcinogenic to humans. Therefore, a dietary exposure assessment for 
the purpose of assessing cancer risk is unnecessary.
    iv. Anticipated residue and PCT information. FFDCA section 
408(b)(2)(E) authorizes EPA to use available data and information on 
the anticipated residue levels of pesticide residues in food and the 
actual levels of pesticide residues that have been measured in food. If 
EPA relies on such information, EPA must require pursuant to FFDCA 
section 408(f)(1) that data be provided 5 years after the tolerance is 
established, modified, or left in effect, demonstrating that the levels 
in food are not above the levels anticipated. For the present action, 
EPA will issue such data call-ins as are required by FFDCA section 
408(b)(2)(E) and authorized under FFDCA section 408(f)(1). Data will be 
required to be submitted no later than 5 years from the date of 
issuance of this tolerance.
    EPA did not use PCT information in the dietary exposure assessment 
for thiamethoxam. 100 PCT was assumed for all food commodities.
    2. Dietary exposure from drinking water. EPA has revised the 
thiamethoxam drinking water assessment since the February 15, 2017, 
rulemaking (82 FR 10712) (FRL-9957-00). Based on the Pesticide in Water 
Calculator's version 1.52, the estimated drinking water concentrations 
(EDWCs) of thiamethoxam in groundwater are 63 parts per billion (ppb) 
for acute exposures and 58 ppm for chronic exposures. Groundwater EDWCs 
were used in the dietary assessment for all sources of drinking water. 
Further information regarding EPA drinking water models used in 
pesticide exposure assessment can be found at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/models-pesticide-risk-assessment.
    3. From non-dietary exposure. The term ``residential exposure'' is 
used in this document to refer to non-occupational, non-dietary 
exposure (e.g., from lawn and garden pest control, indoor pest control, 
termiticides, and flea and tick control on pets). There are no new 
proposed residential uses for thiamethoxam at this time. However, 
thiamethoxam is currently registered for the following uses that could 
result in residential handler and post-application short-term dermal, 
inhalation, and incidental oral exposures: turf (including residential 
lawns and golf courses), gardens and trees, and indoor environments (as 
a crack and crevice treament). Worst-case residential exposure 
scenarios for adults and children were included in the aggregate risk 
estimates and were associated with post-application exposures from 
treated gardens, golf courses, and indoor spraying on carpets.
    4. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.'' In 2016, EPA's Office of 
Pesticide Programs released a guidance document entitled ``Pesticide 
Cumulative Risk Assessment: Framework for Screening Analysis.'' The 
Agency has utilized this framework for thiamethoxam and determined that 
thiamethoxam along with clothianidin, acetamiprid, dinotefuran, 
imidacloprid, nithiazine, and thiacloprid form a candidate common 
mechanism group (CMG). This group of pesticides, referred to as 
neonicotinoids, is considered a candidate CMG because they share 
characteristics to support a testable hypothesis for a common mechanism 
of action for neonicotinoids. Following this determination, the Agency 
conducted an initial and updated screening-level cumulative risk 
assessment consistent with the 2016 guidance document, which indicated 
that cumulative risk estimates for neonicotinoids are below the 
Agency's levels of concern. The Agency has determined that exposures 
from the petitioned-for tolerance are not anticipated to affect the 
overall results of the previous cumulative assessment. Therefore, there 
are no cumulative risks of concern, and the neonicotinoid cumulative 
assessment does not need to be updated for this action.

E. Safety Factor for Infants and Children

    EPA continues to conclude that there are reliable data to support 
the reduction of the 10X Food Quality Protection Act (FQPA) safety 
factor to 1X. See Unit III.D. of the February 15, 2017, rulemaking (82 
FR 10712) (FRL-9957-00) for a discussion of the Agency's rationale for 
that determination.

F. Aggregate Risks and Determination of Safety

    EPA determines whether acute and chronic dietary pesticide 
exposures are safe by comparing aggregate exposure estimates to the 
acute population adjusted dose (aPAD) and chronic population adjusted 
dose (cPAD). For linear cancer risks, EPA calculates the lifetime 
probability of acquiring cancer given the estimated aggregate exposure. 
Short-, intermediate-, and chronic-term risks are evaluated by 
comparing the estimated aggregate food, water, and residential exposure 
to the appropriate PODs to ensure that an adequate margin of exposure 
(MOE) exists. Where different routes of exposure have different levels 
of concern, the Agency uses the aggregate risk index approach for 
calculating short-, intermediate-, and long-term aggregate risk 
estimates.
    1. Acute dietary risk. The acute dietary risk estimates for 
thiamethoxam are not of concern. Using the exposure assumptions 
discussed in this unit for acute exposure, EPA has concluded that

[[Page 59396]]

acute exposure to thiamethoxam from food and water is 13% of the aPAD 
for all infants (less than 1 year old), the population group receiving 
the greatest exposure.
    2. Chronic dietary risk. The chronic dietary risk estimates for 
thiamethoxam are not of concern. Using the exposure assumptions 
described in this unit for chronic exposure, EPA has concluded that 
chronic exposure to thiamethoxam from food and water is 75% of the cPAD 
for children 1-2 years old, the population group receiving the greatest 
exposure.
    3. Short-term risk. Short-term aggregate exposure takes into 
account short-term residential exposure plus chronic exposure to food 
and water (considered to be a background exposure level). Thiamethoxam 
is currently registered for uses that could result in short-term 
residential exposure, and the Agency has determined that it is 
appropriate to aggregate chronic exposure through food and water with 
short-term residential exposures to thiamethoxam. Using the exposure 
assumptions described in this unit for short-term exposures, the MOEs 
for children (490 and 160) and adults (120) are greater than their 
respective LOCs of 100. As a result, the short-term aggregate risk 
estimates are not of concern for the general U.S. population or any 
population subgroup.
    4. Intermediate- and long-term risk. Intermediate- and long-term 
aggregate exposure takes into account intermediate-term residential 
exposure plus chronic exposure to food and water (considered to be a 
background exposure level). For thiamethoxam, residential exposures are 
not expected to occur for intermediate-term duration (1-6 months); 
therefore, intermediate- and long-term risk were not assessed.
    5. Aggregate cancer risk for U.S. population. Thiamethoxam is 
classified as ``Not likely to be carcinogenic to humans''; therefore, 
EPA does not expect thiamethoxam exposures to pose an aggregate cancer 
risk.
    6. Determination of safety. Based on the risk assessments and 
information described above, EPA concludes that there is a reasonable 
certainty that no harm will result to the general population, or to 
infants and children, from aggregate exposure to thiamethoxam residues. 
More detailed information on this action can be found in the 
Thimethoxam Human Health Risk Assessment and the Clothianidin Human 
Health Risk Assessment, which are available in the docket for this 
action.

IV. Other Considerations

A. Analytical Enforcement Methodology

    An adequate method, HPLC Method AG-675, is available to enforce the 
recommended tolerance. The method may be requested from: Chief, 
Analytical Chemistry Branch, Environmental Science Center, 701 Mapes 
Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905; email 
address: [email protected].

B. International Residue Limits

    In making its tolerance decisions, EPA seeks to harmonize U.S. 
tolerances with international standards whenever possible, consistent 
with U.S. food safety standards and agricultural practices. EPA 
considers the international maximum residue limits (MRLs) established 
by the Codex Alimentarius Commission (Codex), as required by FFDCA 
section 408(b)(4). The Codex Alimentarius is a joint United Nations 
Food and Agriculture Organization/World Health Organization food 
standards program, and it is recognized as an international food safety 
standards-setting organization in trade agreements to which the U.S. is 
a party. EPA may establish a tolerance that is different from a Codex 
MRL; however, FFDCA section 408(b)(4) requires that EPA explain the 
reasons for departing from the Codex level.
    Neither Codex nor Canada's Pest Management Regulatory Agency have 
established a MRL for thiamethoxam in or on black pepper. Therefore, 
there are no harmonization issues regarding the establishment of a 
tolerance without a U.S. registration on black pepper.

C. Effective and Expiration Date(s)

    In general, a tolerance action is effective on the date of 
publication of the final rule in the Federal Register. For actions in 
the final rule that lower or revoke existing tolerances, EPA will set 
an expiration date for the existing tolerance of six months after the 
date of publication of the final rule in the Federal Register, in order 
to allow a reasonable interval for producers in exporting members of 
the World Trade Organization's Sanitary and Phytosanitary Measures 
Agreement to adapt to the requirements.

V. Conclusion

    Therefore, a tolerance is established for residues of thiamethoxam, 
in or on pepper, black at 0.15 ppm.

VI. Statutory and Executive Order Reviews

    Additional information about these statutes and executive orders 
can be found at https://www.epa.gov/laws-regulations/laws-and-executive-orders.

A. Executive Order 12866: Regulatory Planning and Review

    This action is exempt from review under Executive Order 12866 (58 
FR 51735, October 4, 1993), because it establishes or modifies a 
pesticide tolerance or a tolerance exemption under FFDCA section 408 in 
response to a petition submitted to the Agency. The Office of 
Management and Budget (OMB) has exempted these types of actions from 
review under Executive Order 12866.

B. Executive Order 14192: Unleashing Prosperity Through Deregulation

    Executive Order 14192 (90 FR 9065, February 6, 2025) does not apply 
because actions that establish a tolerance under FFDCA section 408 are 
exempted from review under Executive Order 12866.

C. Paperwork Reduction Act (PRA)

    This action does not impose an information collection burden under 
the PRA 44 U.S.C. 3501 et seq., because it does not contain any 
information collection activities.

D. Regulatory Flexibility Act (RFA)

    Since tolerance actions that are established on the basis of a 
petition under FFDCA section 408(d), such as the tolerance in this 
final rule, do not require the issuance of a proposed rule, the 
requirements of the RFA, 5 U.S.C. 601 et seq., do not apply to this 
action.

E. Unfunded Mandates Reform Act (UMRA)

    This action does not contain an unfunded mandate of $100 million or 
more (in 1995 dollars and adjusted annually for inflation) as described 
in UMRA, 2 U.S.C. 1531-1538, and does not significantly or uniquely 
affect small governments. The action imposes no enforceable duty on any 
state, local or tribal governments or on the private sector.

F. Executive Order 13132: Federalism

    This action does not have federalism implications as specified in 
Executive Order 13132 (64 FR 43255, August 10, 1999), because it will 
not have substantial direct effects on the states, on the relationship 
between the national government and the states, or on the distribution 
of power and

[[Page 59397]]

responsibilities among the various levels of government.

G. Executive Order 13175: Consultation and Coordination With Indian 
Tribal Governments

    This action does not have Tribal implications as specified in 
Executive Order 13175 (65 FR 67249, November 9, 2000), because it will 
not have substantial direct effects on Tribal governments, on the 
relationship between the federal government and the Indian Tribes, or 
on the distribution of power and responsibilities between the federal 
government and Indian Tribes.

H. Executive Order 13045: Protection of Children From Environmental 
Health Risks and Safety Risks

    This action is not subject to Executive Order 13045 (62 FR 19885, 
April 23, 1997) because tolerance actions like this one are exempt from 
review under Executive Order 12866. However, EPA's 2021 Policy on 
Children's Health applies to this action. This rule finalizes a 
tolerance action under the FFDCA, which requires EPA to give special 
consideration to exposure of infants and children to the pesticide 
chemical residue in establishing a tolerance and to ``ensure that there 
is a reasonable certainty that no harm will result to infants and 
children from aggregate exposure to the pesticide chemical residue . . 
.'' (FFDCA 408(b)(2)(C)). The Agency's consideration is summarized in 
Unit III.D.

I. Executive Order 13211: Actions Concerning Regulations That 
Significantly Affect Energy Supply, Distribution or Use

    This action is not subject to Executive Order 13211 (66 FR 28355) 
(May 22, 2001) because it is not a significant regulatory action under 
Executive Order 12866.

J. National Technology Transfer Advancement Act (NTTAA)

    This action does not involve technical standards that would require 
Agency consideration under NTTAA section 12(d), 15 U.S.C. 272.

K. Congressional Review Act (CRA)

    This action is subject to the CRA, 5 U.S.C. 801 et seq., and EPA 
will submit a rule report to each House of the Congress and to the 
Comptroller General of the United States. This action is not a ``major 
rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: December 17, 2025.
Charles Smith,
Director, Registration Division, Office of Pesticide Programs.

    For the reasons set forth in the preamble, EPA is amending 40 CFR 
chapter I as follows:

PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES 
IN FOOD

0
1. The authority citation for part 180 continues to read as follows:

    Authority: 21 U.S.C. 321(q), 346a and 371.


0
2. Amend Sec.  180.565, by:
0
a. Adding the following commodity in alphabetical order to the table in 
paragraph (a): ``Pepper, Black''; and
0
b. Adding footnote 3 to the table in paragraph (a).
    The additions read as follows:


Sec.  180.565  Thiamethoxam; tolerances for residues.

    (a) * * *

                        Table 1 to Paragraph (a)
------------------------------------------------------------------------
                                                               Parts per
                          Commodity                             million
------------------------------------------------------------------------
 
                                * * * * *
Pepper, black \3\...........................................        0.15
 
                                * * * * *
------------------------------------------------------------------------
\1\ There are no U.S. registrations for these commodities as of February
  15, 2017.
\2\ There are no U.S. registrations for these commodities as of June 15,
  2022.
\3\ There are no U.S. registrations for these commodities as of December
  19, 2025.

* * * * *
[FR Doc. 2025-23424 Filed 12-18-25; 8:45 am]
BILLING CODE 6560-50-P